CancerIQ’s technology makes it possible for providers to recognize and empower patients who have increased risk for cancer at scale. Offering patients cancer risk assessment, genetic counseling and genetic testing is the right thing to do, but most hospitals (cancer centers, breast centers and women’s health providers) simply don’t have the time or the resources to do it. CancerIQ’s unique technology enables providers to screen, assess and manage entire patient populations based on individual genetic risks. That means they can prevent deadly, early-onset cancers. Providers who partner with CancerIQ can also improve quality of care and staff satisfaction, increase revenues and efficiencies, address social determinants of health, meet guidelines/requirements, and enhance customer loyalty.
The Senior Product Strategist will take the lead in researching and developing the next generation of CancerIQ products and services. You will identify new opportunities and help develop our long-term strategic plans for future product lines.
Responsibilities
- Conduct rigorous market, competition, and product analysis for new areas where CancerIQ’s cutting-edge technology can bring about significant change
- Track and understand industry trends, research findings and competitive innovations.
- Infuse product roadmaps with both qualitative and quantitative data evidence
- Communicate product strategy and roadmap to create common understanding and support from senior leadership and stakeholders.
- Translate product domain problems, solutions, and technology to inform strategy and use cases.
- Prioritize and execute a backlog of product discovery projects to drive commercial growth and achieve key operational KPIs.
- Collaborate with cross functional teams to develop or support sales and marketing efforts or go-to-market strategies.
- Work collaboratively with an interdisciplinary team to test hypotheses during product discovery.
Requirements
Qualifications
- 2+ years in a consulting or strategy role with background working across multiple business areas or industries
- 2+ years of healthcare industry experience (providers, genomics, diagnostics, pharma, payers), software, and ideally enterprise SaaS
- An undergraduate university major or minor in a technical discipline (Engineering, Computer Science, Physical Sciences, Math, Applied Economics) or biology/life sciences
- MBA preferred
- Startup or early-stage venture experience preferred
- While this is not technical product management position, it is a bonus if candidates have the ability to understand tradeoffs of different available technologies and systems
What we're looking for
- Business and Industry Insight: Able to use existing strong knowledge of the healthcare ecosystem to identify and understand new product opportunities
- Business Value Identification: Able to isolate and identify key stakeholder problems and key value propositions for new product opportunities
- Reasoning & Critical Thinking: Uses logic and reasoning to better become an expert, and to explain the pros/cons of alternatives not chosen. Able to gain deep understanding of a topic and distill down to the most important points.
- Communications: Able to use simple and concise communications, simplify complicated work of others, intuitively use tables or diagrams in cases where a picture is worth a thousand words.
Benefits
- Competitive pay and benefits (health insurance, travel subsidies, discount programs)
- Passionate, high-energy culture. Surrounding yourself with people that are excited to get stuff done and make an impact is motivating, and addictive.
- Building things to save lives.
Note: At CancerIQ, the safety and wellness of our employees is our top priority. To provide our employees with the support they may need to maintain their personal health and wellness, our office is open and available for those employees who are interested in using it. Our long-term goal is for CancerIQ employees to return to our Chicago office, however working remotely will be an option until everyone is comfortable, and it is 100% safe for all to return.
